MEDICINE
PHIVIDA ’ S FOUNDER AND CEO John-David Belfontaine started out in the food and pharma industry as a wholesale CBD ( cannabidiol ) hemp oil commodities broker with partners in Europe and across the US . Phivida now has major distribution partners for its CBD products , and is preparing for the commercialisation and launch of a strategic suite of CBD infused foods and beverages alongside a range of clinical grade products for healthcare practitioners . With a promotional drive currently focusing on Washington , Oregon and California in the US , the company is also making inroads to expansion into new markets in Asia and the UK .
“ We ’ ve gone from being a commodities-based wholesale farming company into one that focuses on creating branded formulations of CBD infused natural health products eligible for sale in stores ,” explains Belfontaine . “ Compared with other products , we ’ re offering the medicine but none of the side effects . We ’ re all about health ,
not the high . We want to offer products to people that will not only treat their conditions with a therapeutic dose of cannabinoids with full-spectrum hemp oil extract , but also have an element of nutrition combined with a supplementary regimen for a more holistic approach to alternative plant health .” Belfontaine has attracted an advisory board chaired
44 April 2018